Loading clinical trials...
Loading clinical trials...
A Multicenter, Dose-exploration, Open-label Phase II Study to Evaluate the Efficacy and Safety of EDP167 in Adult Patients With Homozygous Familial Hypercholesterolaemia
Conditions
Interventions
EDP167
Locations
1
China
Fuwai Hospital
Beijing, China
Start Date
February 6, 2026
Primary Completion Date
October 4, 2026
Completion Date
March 31, 2027
Last Updated
March 27, 2026
NCT06832371
NCT02651675
NCT01070966
Lead Sponsor
Eddingpharm (Zhuhai) Co., Ltd.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions